Rabies nursing: assessment, post-exposure prophylaxis, and NCLEX review

Rabies is a viral zoonosis caused by the rabies lyssavirus — a nearly universally fatal encephalitis once clinical symptoms appear, yet almost entirely preventable with timely post-exposure prophylaxis (PEP). For nursing students, rabies is a high-stakes test of two competencies at once: the recognition of a rare but catastrophic infectious disease, and the ability to act decisively on the one intervention that saves lives — wound care and prophylaxis initiated within hours of exposure. In the United States, an average of one to three human deaths occur annually, almost always in people who did not receive or complete PEP after a bat or other animal exposure. This reference covers the pathophysiology, clinical stages, nursing assessment, diagnostic workup, PEP protocol in precise detail, isolation precautions, mandatory reporting requirements, and NCLEX practice questions targeting the highest-yield concepts.

Fast-scan summary: rabies

Pathophysiology

Rabies is caused by the rabies lyssavirus, a member of the Rhabdoviridae family. It is a bullet-shaped, enveloped, single-stranded negative-sense RNA virus. The surface glycoprotein (G protein) is the primary determinant of neurotropism and is the target of neutralizing antibodies induced by vaccination and immunoglobulin.

Viral entry and axonal transport

Infection begins when virus-laden saliva from an infected animal contacts broken skin or mucous membranes — almost always through a bite. After local replication in muscle cells near the inoculation site, the virus binds to receptors on peripheral nerve endings, most critically nicotinic acetylcholine receptors at the neuromuscular junction. Once bound, it undergoes retrograde axonal transport — traveling along peripheral nerve axons toward the cell body in the dorsal root ganglia and then onward to the spinal cord and brain. Retrograde axonal transport is also the entry mechanism for tetanus toxin (tetanospasmin), though the CNS targets and clinical outcomes differ dramatically: rabies destroys neurons and causes encephalitis, while tetanus toxin silences inhibitory interneurons and causes spastic paralysis — see the tetanus nursing reference for a direct comparison. This neuronal highway explains the most clinically important feature of rabies: incubation period depends on the distance from the bite site to the central nervous system. A bite on the face or neck may produce symptoms within weeks; a bite on the foot may have an incubation period of months to over a year.

During transport, the virus does not replicate in the bloodstream or lymphatics — it travels purely within neurons. This is why conventional antiviral drugs and systemic immune responses fail to halt infection once transport is underway. The virus is neurologically sequestered from the outset.

CNS spread and Negri body formation

Once the virus reaches the brain, it disseminates rapidly throughout the CNS via anterograde axonal transport. Widespread involvement of the brainstem, limbic system, and cerebral cortex produces the clinical syndrome of rabies encephalitis. Histologically, the hallmark finding is the Negri body — an eosinophilic intracytoplasmic inclusion found in hippocampal neurons (Purkinje cells of the cerebellum and pyramidal cells of the hippocampus). Negri bodies represent viral nucleocapsids and are pathognomonic for rabies on post-mortem examination, though they are found in only 70–90% of cases. Diagnosis during life relies on other methods.

Following CNS replication, the virus spreads centrifugally outward from the brain to peripheral tissues — including the salivary glands, cornea, skin, and other organs. This centrifugal spread is what makes saliva infectious and enables ante-mortem testing of skin and corneal tissue.

Clinical presentation

Prodromal phase (2–10 days)

The prodromal phase is clinically nonspecific and is frequently mistaken for influenza or another viral illness. Key features include:

• Fever, malaise, and headache
• Nausea, vomiting, and anorexia
• Cough, sore throat, and abdominal discomfort
• Paresthesia or pruritus at the healed bite site — this is the most clinically significant early finding and is considered pathognomonic for rabies in a patient with a known exposure history

The paresthesia and pruritus at the bite site reflect early dorsal root ganglion involvement as the virus enters the CNS. The bite wound itself may have fully healed by this point, making the connection to exposure easy to miss. Nursing assessment that elicits the history of animal exposure and specifically asks about sensory changes at old wound sites is essential.

Acute neurological phase (2–7 days)

The acute phase follows the prodrome and takes one of two forms:

Encephalitic (furious) rabies — approximately 80% of cases

Encephalitic rabies is the classic presentation, dominated by autonomic instability and the distinctive behavioral features of hydrophobia and aerophobia:

• Hydrophobia: intense pharyngeal and laryngeal spasms triggered by attempts to swallow liquids. The patient sees or hears water and experiences overwhelming fear combined with painful spasm. Over time, the sight or even the sound of water triggers spasm without any swallowing attempt. This reflects brainstem dysfunction — hyperexcitability of the neurons coordinating swallowing.
• Aerophobia: similar laryngeal spasms triggered by a puff of air on the face or any current of air; considered highly specific for rabies.
• Hypersalivation: the patient is unable to swallow saliva, producing the classic “foaming at the mouth” appearance.
• Agitation, confusion, and combativeness alternating with periods of lucidity
• Autonomic instability: tachycardia, fluctuating blood pressure, hyperthermia, diaphoresis, pupillary irregularity
• Hallucinations and bizarre behavior
• Priapism in males

Paralytic (dumb) rabies — approximately 20% of cases

Paralytic rabies is less recognized and is frequently misdiagnosed as Guillain-Barré syndrome or other demyelinating illness:

• Ascending flaccid paralysis beginning in the bitten extremity
• Weakness progresses proximally and then to other limbs
• Sphincter dysfunction
• Hydrophobia is often absent or mild, making diagnosis more difficult
• Progression to quadriplegia, respiratory failure, and coma

Both forms progress through:

• Coma (within 2–10 days of neurological phase onset)
• Respiratory failure, cardiac arrhythmias, multi-organ failure
• Death (virtually always within days of coma onset in untreated patients)

Nursing assessment

History and exposure assessment

A thorough exposure history is the most critical component of assessment. Obtain:

• Date, location, and circumstances of animal contact
• Animal species, behavior (unprovoked attack, nocturnal bat in daylight, animal acting strangely), and vaccination status
• Whether the animal is available for observation or testing
• Previous rabies vaccination history (pre-exposure prophylaxis or prior PEP)
• Immunocompromised status (affects PEP response and titre monitoring)

For bat exposures: ask whether the patient was sleeping in a room where a bat was found, or whether an unattended young child or intoxicated adult was in the room with a bat. A bite from a bat may leave no visible mark — PEP is indicated for any of these scenarios.

Neurological assessment

For patients with suspected clinical rabies (rare), perform a focused neuro assessment using the vital signs by age baseline and standard neurological monitoring components:

• Level of consciousness and orientation using the Glasgow Coma Scale
• Cranial nerve assessment (cranial nerves IX and X involvement drives hydrophobia)
• Motor strength and symmetry — ascending weakness suggests paralytic form
• Deep tendon reflexes
• Presence and character of agitation (is it purposeful? intermittent? worsening?)
• Autonomic signs: heart rate, blood pressure, temperature, diaphoresis, pupil size and reactivity

Hydrophobia and aerophobia assessment

Do NOT deliberately test for hydrophobia by offering water or directing air at a patient with suspected rabies. These stimuli can precipitate severe laryngospasm, respiratory compromise, and extreme patient distress. Document hydrophobia or aerophobia if the patient reports it or if spasms occur during routine care. Hydrophobia testing as a diagnostic technique is obsolete and contraindicated.

Respiratory monitoring

Patients in the acute neurological phase require continuous respiratory monitoring:

• Respiratory rate and pattern (Cheyne-Stokes or ataxic breathing indicates brainstem compromise)
• Oxygen saturation via continuous pulse oximetry
• Ability to handle secretions and swallow safely (assess for drooling, pooling of secretions)
• Prepare for early intubation — secretion management and airway protection deteriorate rapidly; intubation is also associated with aerosol generation and requires full PPE (see isolation section)

Diagnostic workup

Ante-mortem diagnosis of rabies is challenging. There is no single definitive test, and a combination of specimens is required. Early in infection, all tests may be negative despite active disease.

Coordinate specimen collection and processing with your state health department and the CDC. All rabies testing in the US outside of the post-mortem brain DFA is conducted through state public health laboratories. Samples must be packaged and transported as biological hazard specimens per IATA regulations.

Key nursing role in diagnostics: Facilitate collection of appropriate specimens by obtaining the correct container and transport media from laboratory ahead of time; label all specimens as potential rabies exposure; follow contact precautions during specimen collection; document time, date, and anatomical site of each specimen clearly.

Compare CSF findings to viral meningitis-nursing patterns — rabies CSF typically shows mild lymphocytic pleocytosis similar to aseptic meningitis, not the neutrophilic predominance of bacterial meningitis.

Nursing interventions

Isolation precautions

Rabies is not transmitted by casual contact, respiratory droplets, or the airborne route under routine clinical conditions. The transmission risk to healthcare workers is extremely low with appropriate precautions.

Standard precautions are appropriate for routine care of a patient with rabies when skin is intact and contact with secretions is not anticipated.

Contact precautions (gloves + gown) and eye/face protection are required whenever contact with saliva, CSF, or other potentially infectious secretions is anticipated — this includes any direct patient care, wound care, specimen collection, or personal care activities.

Airborne precautions + contact precautions (N95 respirator, gown, gloves, eye protection) are required for aerosol-generating procedures: endotracheal intubation, suctioning of airway secretions, bronchoscopy, and open tracheostomy care. These procedures aerosolize secretions and are the primary theoretical transmission risk to healthcare staff.

Rabies does NOT require negative pressure isolation under routine care. Patient rooms with standard ventilation are appropriate.

Airway management

Airway compromise is the leading cause of preventable death in the rare patient who survives to hospital admission with clinical rabies. Proactive airway management includes:

• Early anesthesiology/respiratory therapy consultation
• Preparation for rapid sequence intubation using full aerosol precautions
• Suctioning equipment at bedside
• Monitoring for signs of impending respiratory failure: accessory muscle use, paradoxical breathing, declining SpO2, apneic episodes

Sedation and agitation management

Agitation in rabies encephalitis is intense, distressing, and refractory to standard doses. The goal is adequate sedation to prevent injury to the patient and staff and to limit distress:

• Benzodiazepines (lorazepam, midazolam) are the first-line agents for acute agitation
• Opioids (morphine, fentanyl) for pain and comfort — the viral encephalitis causes significant pain
• Sedation-analgesia protocols consistent with ICU guidelines; titrate to comfort
• Minimize sensory triggers: dim lighting, reduce noise, limit stimulation; drafts of air must be avoided (aerophobia triggers)

Palliative care and comfort focus

Once symptomatic rabies encephalitis is established, survival is essentially zero. The Milwaukee Protocol (induced coma plus antivirals) has been attempted in a handful of cases with extremely rare survival; it is not a standard of care, has not been reproduced consistently, and most authorities do not recommend it outside of experimental settings.

The appropriate clinical focus is comfort care and palliation:

• Goals of care discussion with patient (while lucid in early stages) and family
• Palliative care consultation
• Aggressive symptom management for pain, agitation, dyspnea, and secretions
• Spiritual and psychological support for family
• Clear communication about prognosis — rabies encephalitis is fatal; the clinical team should communicate this honestly and compassionately
• Support family presence at bedside within the constraints of isolation precautions

Medications

Post-exposure prophylaxis (PEP)

PEP is the cornerstone of rabies prevention and the single most important clinical concept for nursing students. When initiated promptly after exposure, PEP is virtually 100% effective at preventing rabies. When delayed or omitted, the result is almost always fatal. The three steps of PEP must be understood in sequence and detail.

Step 1: Wound care — the most immediate intervention

Immediately and vigorously wash all wounds with soap and water for a minimum of 15 minutes. This single mechanical step has been demonstrated to reduce transmission risk by up to 90%. The mechanism is physical removal of virus particles from the wound and soap’s direct virucidal effect on the lyssavirus envelope.

Correct wound care:

• Use any soap (bar soap, liquid soap, antiseptic soap)
• Use running water where available; otherwise use a clean water source
• Irrigate wound copiously — the 15-minute duration is not optional
• After soap-and-water washing, apply antiseptic: povidone-iodine (Betadine) or 70% ethanol
• Do NOT suture wounds primarily if possible — suturing may entrap virus in deep tissue; if closure is required for hemostasis or functional reasons, close loosely and after thorough irrigation

See the wound assessment reference for additional wound care principles.

Wound care must happen before or concurrently with RIG and vaccine — never delay wound care to wait for medical orders.

Step 2: Rabies immune globulin (RIG) — passive protection on day 0

RIG provides immediate passive immunity while the vaccine-induced active immune response develops (which takes 7–14 days).

The ACIP-recommended dose of human rabies immune globulin (HRIG) is 20 IU/kg body weight.

Administration technique:

• Infiltrate as much of the calculated dose as anatomically feasible directly into and around the wound site — this places neutralizing antibody where virus concentration is highest
• Any remaining RIG that cannot be infiltrated at the wound (due to wound location or small wound size) is injected intramuscularly at a site distant from the vaccine injection site (typically the contralateral deltoid or anterolateral thigh)
• RIG must be given on Day 0, at the same visit as the first vaccine dose
• If RIG was not given on Day 0, it can still be given up to and including Day 7 after the first vaccine dose; after Day 7, the vaccine-induced immune response is underway and RIG may suppress it — do not give after Day 7
• Never inject RIG and vaccine into the same anatomical site or with the same syringe

Step 3: Vaccine series — active immunization

The rabies vaccine series stimulates active antibody production and confers durable immunity.

For previously unvaccinated patients:

• 4 doses IM: Days 0, 3, 7, and 14
• Both HDCV (Imovax) and PCECV (RabAvert) are effective and interchangeable within a series

For previously vaccinated patients (prior complete PEP series or documented pre-exposure prophylaxis with confirmed antibody titre):

• 2 doses IM only: Days 0 and 3
• No RIG — the existing immune memory responds rapidly; RIG is unnecessary and may blunt the booster response
• Confirm prior vaccination history with documentation; do not rely on patient recall alone for this decision

Injection site: Always the deltoid muscle in adults and older children; anterolateral thigh in infants and young children. The gluteal region is contraindicated — fat composition reduces immunogenicity.

Immunocompromised patients: Standard PEP regimen applies. Serology testing (rabies virus neutralizing antibody titre) should be checked 7–14 days after the final dose to confirm adequate immune response. Consult infectious disease.

When is PEP indicated?

PEP decision-making depends on the exposure type, animal species, and geographic context. The CDC framework:

PEP is indicated for:

• Any bite from a wild carnivore (raccoon, skunk, fox, coyote) or bat
• Any unvaccinated dog, cat, or ferret bite if the animal cannot be observed for 10 days OR if the animal shows signs of illness
• Any mucous membrane or open wound contact with saliva from a potentially rabid animal
• Bat exposure with no visible bite in a sleeping person, unattended child, or intoxicated adult — bat bites are often imperceptible; any bat found in a room with a person unable to rule out contact requires PEP. This is the leading cause of human rabies deaths in the US.

PEP is NOT indicated for:

• Petting or touching an animal (intact skin)
• Contact with blood, urine, feces, or feathers of an animal
• Domestic animal (dog, cat, ferret) bite where the animal remains healthy throughout a 10-day observation period
• Rodent, rabbit, or hare bites (these species are rarely infected with rabies and have not been known to transmit rabies to humans in the US; consult local health department if uncertain)
• Squirrel, hamster, guinea pig, gerbil, chipmunk, rat, mouse bites — same as above

Pre-exposure prophylaxis (PrEP)

Pre-exposure prophylaxis is recommended for individuals at occupational or recreational risk of rabies exposure:

• Veterinarians and veterinary staff
• Animal control officers
• Rabies laboratory workers (highest risk category)
• Travelers spending extended time in countries where canine rabies is endemic (especially if remote areas with limited medical access)
• Wildlife biologists and spelunkers (cave explorers — bat exposure risk)

PrEP regimen: 3 doses of HDCV or PCECV on Days 0, 7, and 21 (or 28). Periodic booster doses and antibody titre checks are required for ongoing high-risk exposure, based on risk category.

PrEP does not eliminate the need for PEP after exposure — it simplifies PEP (2 doses of vaccine, no RIG needed) and provides a safety net if PEP is delayed.

Isolation precautions

Key teaching points on isolation:

• Rabies is NOT transmitted by respiratory droplets or airborne particles under routine conditions; negative pressure rooms are not required
• Casual contact — touching intact skin, being in the same room — carries no transmission risk
• Most healthcare workers who have cared for rabies patients without PPE have not been infected; well-documented healthcare transmission has not occurred in modern clinical settings
• Despite the low transmission risk, rigorous PPE for secretion-contact activities protects staff and provides defensible documentation

Reporting requirements

Rabies (human) is a nationally notifiable disease in the United States. Reporting requirements:

• Report suspected or confirmed human rabies cases to the local or state health department immediately (most jurisdictions require same-day or next-business-day reporting)
• The state health department coordinates with the CDC
• Reporting a potential animal exposure (even before human disease develops) triggers:
  • Animal control involvement for capture, confinement, or testing of the implicated animal
  • Wildlife reservoir identification and geographic risk assessment
  • Coordination of PEP initiation and follow-up
• Confidentiality applies: patient information is protected; the report goes to public health authorities, not disclosed publicly

Nursing role in reporting:

• Notify the attending physician and infection control officer
• Assist with completing the reportable disease form (state-specific format)
• Document the date and time of report and name of receiving health department official
• Ensure animal information (species, location, vaccination status, current whereabouts) is included in the report

NCLEX practice questions

Summary

Rabies is a devastating but preventable disease. The key clinical competencies for nursing students are:

1. Recognize the window for intervention. Rabies is fatal once symptomatic; PEP is virtually 100% effective when given promptly. Every minute between exposure and wound care matters.

2. Wound care first, always. Fifteen minutes of vigorous soap-and-water washing reduces transmission by 90% — it is the most effective single intervention and must happen immediately.

3. Know the PEP protocol precisely. RIG 20 IU/kg infiltrated at the wound on Day 0; vaccine on Days 0, 3, 7, and 14 for unvaccinated patients. For previously vaccinated: Days 0 and 3, no RIG. Never inject RIG and vaccine at the same site.

4. Bat exposures require PEP regardless of visible bite. A bat in a room with a sleeping person or unattended child is a PEP indication — bat bites are often imperceptible and bats are the leading cause of US rabies deaths.

5. Do not test for hydrophobia. Deliberately triggering pharyngeal spasm is contraindicated; document it if it occurs during care.

6. Once encephalitis develops, shift to palliation. Rabies encephalitis is fatal; the nursing role becomes aggressive symptom management, family support, and comfort care.

7. Report immediately. Human rabies cases are nationally notifiable; report to the local or state health department to activate animal control and public health response.

References

• Centers for Disease Control and Prevention. Rabies: Clinical Guidance. Available from: https://www.cdc.gov/rabies/clinical-guidance/index.html
• Centers for Disease Control and Prevention. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies. MMWR Recomm Rep. 2010;59(RR-2):1-9.
• Jackson AC. Rabies. N Engl J Med. 2023;389(22):2082-2090. doi:10.1056/NEJMra2207089
• Manning SE, Rupprecht CE, Fishbein D, et al. Human Rabies Prevention — United States, 2008: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57(RR-3):1-28.
• Warrell DA, Warrell MJ. Rabies: the clinical features, management and prevention of the classic zoonosis. Clin Med (Lond). 2015;15(1):78-81.
• Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352(24):2508-2514. (Milwaukee Protocol original case report)